BioBoss
BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today's most innovative companies. Listen in as Wyant Simboli Principal and branding veteran John Simboli poses the questions "What drives you? How do you create change? Why should people care?" to biopharma leaders and hear insights on this rapidly developing field.
Episodes
81 episodes
Welcome to Season 7 of BioBoss
BioBoss podcast host John Simboli reflects on Seasons 1-6 and invites listeners to Season 7 starting in January 2025
•
Season 7
•
1:17
Sam Clark: Founder and CEO of Terran Biosciences
Sam Clark, founder and CEO of Terran Biosciences, shares his insights with BioBoss host John Simboli about leadership in biopharma and how Terran is working to develop therapeutics and technologies for patients with neurological and psychiatric...
•
Season 6
•
Episode 74
•
40:50
Iain Kilty: CEO of Sitryx
Iain Kilty, CEO of Sitryx, shares his insights about leadership in biopharma and how Sitryx is working to alter immune cell metabolism to resolve disease
•
Season 6
•
Episode 73
•
40:50
Steve Uden: Co-Founder and CEO of Rallybio
Steve Uden, co-founder and CEO of RallyBio, shares his insights about leadership in biopharma and how Rallybio is working to to profoundly change the odds for patients living with rare diseases.
•
Season 6
•
Episode 72
•
31:32
Karine Rossignol: Co-Founder and CEO of Smart Immune
Karine Rossignol, co-founder and CEO of Smart Immune, shares her insights with BioBoss host John Simboli about leadership in biopharma and how Smart Immune is working to harness a patient's own thymus to re-arm the immune system agains...
•
Season 6
•
Episode 71
•
35:56
Erik Buntinx: Founder and CEO of ANeuroTech
Erik Buntinx, founder and CEO of ANeuroTech, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how ANeurotech is working to develop effective treatments, with minimal or no side-effects, for patients ...
•
Season 6
•
Episode 70
•
49:17
Helen Torley: CEO of Halozyme Therapeutics
Helen Torley, CEO of Halozyme Therapeutics, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Halozyme is working to reinvent the patient experience by easing the burden of treatment and improving...
•
Season 6
•
Episode 69
•
39:09
James Graham: CEO of Recce Pharmaceuticals
James Graham, CEO of Recce Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Recce is working to develop a new class of synthetic anti-infectives designed to address the threat of...
•
Season 6
•
Episode 68
•
21:06
Mike Gaffney: CEO of Cellphire Therapeutics
Mike Gaffney, CEO of Cellphire Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Cellphire is working to save lives by bringing novel hemostatic products to patients in need.
•
Season 6
•
Episode 67
•
39:17
David Baram: Founder and CEO of EmendoBio
David Barmam, founder and CEO of Emendio Biotherapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Emendo is working to evolve traditional CRISPR tools and create new nucleases customized...
•
Season 6
•
Episode 66
•
35:41
Welcome to Season 6 of BioBoss
BioBoss podcast host John Simboli reflects on Seasons 1-5 and invites listeners to Season 6 starting in January 2024
•
Season 6
•
0:44
Anat Binur: Co-Founder and CEO of Ukko
Anat Binur, co-founder and CEO of Ukko, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Ukko is working to improve the lives of people who suffer from food allergies.
•
Season 5
•
Episode 65
•
35:42
Markku Jalkanen: Founder and CEO of Faron Pharmaceuticals
Markku Jalkanen, founder and CEO of Faron Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Faron is working to develop new immunotherapies to address unmet medical needs in cance...
•
Season 5
•
Episode 64
•
27:58
Lisa Deschamps: CEO of AviadoBio
Lisa Deschamps, CEO of AviadoBio, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how AviadoBio is working to develop transformative medicines for patients living with debilitating and life-threaten...
•
Season 5
•
Episode 63
•
46:22
Leonard Mazur: Founder and CEO of Citius Pharma
Leonard Mazur, founder and CEO of Citius Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Citius is working to unlock the potential of first-in-class critical care therapeutics, ...
•
Season 5
•
Episode 62
•
32:35
Dario Neri: Co-Founder and CEO of Philogen
Dario Neri, co-founder and CEO of Philogen, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Philogen is working to discover and develop targeted therapies to treat cancer and chronic inflammation.
•
Season 5
•
Episode 61
•
39:13
.jpg)
Naseem Amin: CEO of Orphalan
Naseem Amin, CEO of Orphalan, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Orphalan is working to transform rare disease treatment.
•
Season 5
•
Episode 60
•
43:47
Hartmut Ehrlich: CEO of Abivax
Hartmut Ehrlich, CEO of Abivax, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Abivax is working to develop treatments modulating the body’s natural immune system to treat patients with chronic in...
•
Season 5
•
Episode 59
•
50:11
Ivo Timmermans: Co-Founder and CEO of Pleco Therapeutics
Ivo Timmermans, co-founder and CEO of Pleco Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Pleco is working to develop breakthrough therapies that change the balance in the treatment...
•
Season 5
•
Episode 58
•
41:32
Philipp Spycher: Co-Founder and CEO of Araris Biotech
Philipp Spycher, co-founder and CEO of Araris Biotech, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Araris is working to develop a linker technology for antibody-drug conjugates that enables att...
•
Season 5
•
Episode 57
•
39:22
Patrick Arensdorf: Founder and CEO of Exai Bio
Pat Arensdorf, founder and CEO of Exai Bio, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Exai is working to develop a next-generation RNA-based platform to deliver actionable insight into cancer...
•
Season 5
•
Episode 56
•
39:01
Josh Geballe: Managing Director of Yale Ventures
Josh Geballe, Managing Director of Yale Ventures, shares his thoughts with BioBoss host John Simboli about leadership and community building in biopharma. Yale Ventures is a new initiative created by Yale University to support and expand innova...
•
Season 5
•
Episode 55
•
34:27
Welcome to Season 5 of BioBoss
BioBoss podcast host John Simboli reflects on the success of seasons 1, 2 ,3 and 4 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in BioBoss season 5.John is delighted to...
•
Season 5
•
0:59
